- Home
- BRN vs PHGE Comparison
BRN vs PHGE Comparison
Compare BRN & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- PHGE
- Stock Information
- Founded
- BRN 1956
- PHGE 2015
- Country
- BRN United States
- PHGE Israel
- Employees
- BRN N/A
- PHGE N/A
- Industry
- BRN Oil & Gas Production
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- PHGE Health Care
- Exchange
- BRN Nasdaq
- PHGE Nasdaq
- Market Cap
- BRN 23.7M
- PHGE 26.5M
- IPO Year
- BRN N/A
- PHGE N/A
- Fundamental
- Price
- BRN $1.74
- PHGE $0.75
- Analyst Decision
- BRN
- PHGE Strong Buy
- Analyst Count
- BRN 0
- PHGE 2
- Target Price
- BRN N/A
- PHGE $22.50
- AVG Volume (30 Days)
- BRN 19.4K
- PHGE 151.9K
- Earning Date
- BRN 12-13-2024
- PHGE 11-14-2024
- Dividend Yield
- BRN 3.49%
- PHGE N/A
- EPS Growth
- BRN N/A
- PHGE N/A
- EPS
- BRN N/A
- PHGE N/A
- Revenue
- BRN $24,300,000.00
- PHGE N/A
- Revenue This Year
- BRN N/A
- PHGE N/A
- Revenue Next Year
- BRN N/A
- PHGE N/A
- P/E Ratio
- BRN N/A
- PHGE N/A
- Revenue Growth
- BRN N/A
- PHGE N/A
- 52 Week Low
- BRN $1.62
- PHGE $0.62
- 52 Week High
- BRN $3.20
- PHGE $8.55
- Technical
- Relative Strength Index (RSI)
- BRN 29.56
- PHGE 36.37
- Support Level
- BRN $1.62
- PHGE $0.67
- Resistance Level
- BRN $1.96
- PHGE $0.81
- Average True Range (ATR)
- BRN 0.09
- PHGE 0.09
- MACD
- BRN -0.01
- PHGE 0.00
- Stochastic Oscillator
- BRN 24.39
- PHGE 44.00
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.